485 related articles for article (PubMed ID: 32345788)
1. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
[TBL] [Abstract][Full Text] [Related]
3. Menopausal Hormone Therapy and Risks of First Hospitalized Heart Failure and its Subtypes During the Intervention and Extended Postintervention Follow-up of the Women's Health Initiative Randomized Trials.
Liu L; Klein L; Eaton C; Panjrath G; Martin LW; Chae CU; Greenland P; Lloyd-Jones DM; Wactawski-Wende J; Manson JE
J Card Fail; 2020 Jan; 26(1):2-12. PubMed ID: 31536806
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
[TBL] [Abstract][Full Text] [Related]
5. Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.
Bhupathiraju SN; Grodstein F; Rosner BA; Stampfer MJ; Hu FB; Willett WC; Manson JE
Am J Epidemiol; 2017 Sep; 186(6):696-708. PubMed ID: 28938710
[TBL] [Abstract][Full Text] [Related]
6. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
[TBL] [Abstract][Full Text] [Related]
7. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
Manson JE; Aragaki AK; Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Chlebowski RT; Howard BV; Thomson CA; Margolis KL; Lewis CE; Stefanick ML; Jackson RD; Johnson KC; Martin LW; Shumaker SA; Espeland MA; Wactawski-Wende J;
JAMA; 2017 Sep; 318(10):927-938. PubMed ID: 28898378
[TBL] [Abstract][Full Text] [Related]
8. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
9. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL
JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368
[TBL] [Abstract][Full Text] [Related]
10. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.
Manson JE; Aragaki AK; Bassuk SS; Chlebowski RT; Anderson GL; Rossouw JE; Howard BV; Thomson CA; Stefanick ML; Kaunitz AM; Crandall CJ; Eaton CB; Henderson VW; Liu S; Luo J; Rohan T; Shadyab AH; Wells G; Wactawski-Wende J; Prentice RL;
Ann Intern Med; 2019 Sep; 171(6):406-414. PubMed ID: 31499528
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative.
Wild RA; Hovey KM; Andrews C; Robinson JG; Kaunitz AM; Manson JE; Crandall CJ; Paragallo R; Shufelt C; Merz CNB
Menopause; 2021 May; 28(6):610-618. PubMed ID: 33950030
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
Swica Y; Warren MP; Manson JE; Aragaki AK; Bassuk SS; Shimbo D; Kaunitz A; Rossouw J; Stefanick ML; Womack CR
Menopause; 2018 Jul; 25(7):753-761. PubMed ID: 29381666
[TBL] [Abstract][Full Text] [Related]
13. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials.
Jiang X; Aragaki AK; Nudy M; Manson JE; Shadyab AH; Wild RA; Valdiviezo C; Gass M; Martin LW; Pan K; Stefanick ML; Robbins JA; Schnatz PF
Menopause; 2023 Jan; 30(1):28-36. PubMed ID: 36256926
[TBL] [Abstract][Full Text] [Related]
14. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
15. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapy and the incidence of carpal tunnel syndrome in postmenopausal women: Findings from the Women's Health Initiative.
Al-Rousan T; Sparks JA; Pettinger M; Chlebowski R; Manson JE; Kauntiz AM; Wallace R
PLoS One; 2018; 13(12):e0207509. PubMed ID: 30513095
[TBL] [Abstract][Full Text] [Related]
17. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
Heiss G; Wallace R; Anderson GL; Aragaki A; Beresford SA; Brzyski R; Chlebowski RT; Gass M; LaCroix A; Manson JE; Prentice RL; Rossouw J; Stefanick ML;
JAMA; 2008 Mar; 299(9):1036-45. PubMed ID: 18319414
[TBL] [Abstract][Full Text] [Related]
18. Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.
Zhao S; Chlebowski RT; Anderson GL; Kuller LH; Manson JE; Gass M; Patterson R; Rohan TE; Lane DS; Beresford SA; Lavasani S; Rossouw JE; Prentice RL
Breast Cancer Res; 2014 Mar; 16(2):R30. PubMed ID: 24670297
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic Effects of Hormone Therapy and Associations With Coronary Heart Disease Among Postmenopausal Women.
Balasubramanian R; Demler O; Guasch-Ferré M; Paynter NP; Sheehan R; Liu S; Manson JE; Salas-Salvadó J; Martínez-Gonzalez MÁ; Hu FB; Clish C; Rexrode KM
Circ Genom Precis Med; 2020 Dec; 13(6):e002977. PubMed ID: 33141616
[TBL] [Abstract][Full Text] [Related]
20. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
